Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Payers

Researchers Explore Organ Recovery and Transplantation Opportunities

Although nearly half of US adults are registered organ donors, transplant waitlists remain long. New research outlines how to accelerate improvement and offers key considerations for payers and regulators.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

Go-to brands address society's challenges and pull us into a company's inner world. For these brands, value dictates progress.

Senior Partner, Brand Strategy, Lippincott
Partner, Lippincott
Partner, Health and Life Sciences, Oliver Wyman

With bid season approaching, payers' pharmacy teams must re-evaluate how to competitively position themselves for success.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

How Market Trends and Dynamics are Impacting Insurers' Bottom Lines

An analysis of market profitability and capitalization trends as well as new insights into insurers' recent claims experiences.

Principal, Actuarial, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe

The ideal Stars leader of tomorrow needs a specific skill set to produce consistently high Stars rating results for an organization.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness, Health and Life Sciences, Oliver Wyman
Former President of Government Business, Anthem/BCBSM, Senior Adviser, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

An executive interview with Bruce Broussard on Humana's strategic pillars, partnership decisions, and ongoing resiliency.

President and CEO, Humana

How HRAs can empower employees to choose the coverage that meets their needs while empowering employers to offer competitive health choices.

Founder and CEO, Softheon
Principal, Wild Blue Health Solutions

Part 4: State-by-State Market Impact

Six factors that dictate the kind of health coverage people who've lost their jobs want next.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman

Healthcare Cost and Utilization During COVID-19

An analysis of what claim payments and delays may look like later this year.

Practice Leader, Oliver Wyman Actuarial Consulting
Principal, Actuarial, Oliver Wyman

Insights in your inbox

Subscribe